Literature cited
S. D. Yuzhakov and A. V. Morozov, Byull. Eksp. Biol. Med., No. 4, 53–60 (1983).
W. R. Adam, E. J. Meagher, and C. E. Barter, Clin., Exp. Hypertens.,A4, 1419–1428 (1982).
J. L. Anderson, H. E. Rodler, and L. S. Green, Am. J. Cardiol.,51, 1196–1202 (1983).
O. Andersson, G. Berglund, and L. Hansson, Br. J. Clin. Pharmacol.,3, Suppl. No. 3, 757–761 (1976).
H. Asada, N. T. Iton, H. Suzuki, et al., J. Pharmacol. Exp. Ther.,223, 560–572 (1982).
M. Asano, H. Hashimoto, and M., Nakashima, Arch. Inst. Pharmacodyn.,262, 34–46 (1983).
J. Bahlmann, J. Brod, W. Hubrich, et al., Br. J. Clin. Pharmacol.,8, Suppl. No. 2, 113S-117S (1979).
T. Baum, and E. J. Sybertz, Fed. Proc.,42, 176–181 (1983).
A. G. H. Blakeley and R. J. Summers, Gen. Pharmacol.,9, 399–402 (1978).
R. T. Brittain and G. P. Levy, Br. J. Clin. Pharmacol.,3, Suppl. No. 3, 681–694 (1976).
R. N. Brogden, R. C. Heel, T. M. Speight, et al., Drugs,15, 251–270 (1978).
B. Carey and E. T. Whalley, Br. J. Pharmacol.,67, 13–15 (1979).
J. R. Carpenter, Br. J. Pharmacol.,72, 532–533 (1981).
D. A. Chamberlain and R. Vincent, Drugs,28, Suppl. No. 2, 88–102 (1984).
M. Chaeriello, G. Brevetti, G. De Rosa, et al., Am. J. Cardiol.,46, 249–254 (1980).
H. C. Cheng, O. K. Reaves, J. M. Grisar, et al., Life Sci.,27, 2529–2534 (1980).
A. Clancy, J. A. Steiner, A. Maughamk, et al., Br. J. Clin. Pharmacol.,11, 428–431 (1981).
M. L. Cohen and L. M. Hynes, Clin. Exp. Ther.,5, 563–575 (1983).
J. N. Cohn, J. Metha, and G. S. Francis, Br. J. Clin. Pharmacol.,13, Suppl. No. 1, 19S-26S (1982).
R. C. Dage, H. C. Cheng, C. P. Hsieh, et al., Fed. Proc.,37, 663 (1978).
G. S. Deacon, M. S. Lennard, N. D. S. Bax, et al., Br. J. Pharmacol.,12, 429–431 (1981).
H. L. Elliott, P. A. Meredith, D. J. Summer, et al., Br. J. Clin. Pharmacol.,17, 208–215 (1984).
J. B. Farmer, I. Kennedy, G. P. Levy, et al., Br. J. Pharmacol.,45, 660–675 (1972).
W. H. Frishman, J. Strom, T. H. Le Jemtel, et al., Am. J. Cardiol.,48, 917–928 (1981).
R. Gagnon, M. Morissette, S. Presant, et al., Am. J. Cardiol.,49, 1267 (1982).
J. S. Gill and D. G. Beevers, Eur. J. Clin. Pharmacol.,27, 265–268 (1984).
D. H. Globar and R. A. Kloner, Am. J. Cardiol.,47, 430 (1981).
E. H. Gold, W. Chang, M. Cohen, et al., J. Med. Chem.,25, 1363–1370 (1982).
A. A. Hancock, Clin. Exp. Hypertens.,A6, 659–684 (1984).
H. Hashimoto, M. Asano, T. Hayashi, et al., Arch. Int. Pharmacodyn.,267, 23–24 (1984).
J. Jarrott, W. J. Louis, and R. J. Summers, Br. J. Pharmacol.,75, 401–408 (1982).
B. E. Karlberg, Eur. J. Clin. Pharmacol.,25, 179–186 (1983).
J. Kennedy and G. P. Levy, Br. J. Pharmacol.,53, 585–592 (1975).
P. Kofod, S. Vejl, K. Kjaer, et al., Postgrad. Med. J.,56, Suppl. No. 2, 69–74 (1980).
W. E. Kreighbaum, W. L. Matier, R. D. Dennis, et al., J. Med. Chem.,23, 285–289 (1980).
K. Kubo, J. Nakamura, A. Karagawa, et al., Arzneim.-Forsch.,33, 926–931 (1983).
A. Lehtonen, H. Allonen, and T. Kleimola, Int. J. Clin. Pharmacol.,17, 71–75 (1979).
M. Lilja, A. J. Jounela, and H. Karppanen, Eur. J. Clin. Pharmacol.,21, 363–367 (1982).
W. J. Louis, J. J. McNeil, and O. H. Drummer, Drugs,28, Suppl. No. 2, 16–34 (1984).
P. Lund-Johansen, Drugs,28, 35–50 (1984).
P. L. Malini, E. Strocchi, S. Negroni, et al., Br. J. Pharmacol.,13, 123S-126S (1982).
P. L. Malini, E. Strocchi, and E. Ambrosioni, Br. J. Pharmacol.,17, 251–255 (1984).
G. M. Maxwell, Br. J. Pharmacol.,49, 370–372 (1973).
J. J. McNeill and W. J. Louis, Br. J. Clin. Pharmacol.,8, Suppl. No. 2, 163S-166S (1979).
J. Mehta, R. L. Feldman, J. D. Marx, et al., Am. J. Med.,75, 32–39 (1983).
A. Miyagishi, H. Nakahara, and Y. Hara, Arch. Int. Pharmacodyn.,271, 249–262 (1984).
A. Monopoli, F. Bamonte, A. Forlani, et al., Arch. Int. Pharmacodyn.,272, 256–263 (1984).
Y. Nakagawa, N. Shimamoto, M. Nakazawa, et al., Jpn. J. Pharmacol.,30, 743–745 (1980).
G. I. C. Nelson, R. C. Ahuja, M. Hussain, et al., J. Cardiovasc. Pharmacol.,4, 921–924 (1982).
H. F. Oates, L. M. Stoker, and G. S. Stokes, Arch. Int. Pharmacodyn.,251, 95–102 (1981).
R. M. Pearson, D. N. W. Griffith, M. Woollard, et al., Br. J. Clin. Pharmacol.,8, Suppl. No. 12 195S-198S (1979).
S. M. Pogwizd, A. D. Sharma, and P. B. Corr, Cardiovasc. Res.,16, 398–401 (1982).
B. N. C. Prichard and A. J. Boakes, Br. J. Clin. Pharmacol.,3, 743–750 (1976).
B. N. C. Prichard, Drugs,28, Suppl. No. 2, 51–68 (1984).
D. J. Pugsley, B. K. Armstrong, M. A. Nassim, et al., Br. J. Clin. Pharmacol.,3, Suppl. No. 3, 777–782 (1976).
M. J. Rand, M. W. McCulloch, and D. F. Story, Central Action of Drugs in Blood Pressure Regulation, London (1975), p. 94.
S. Rastnussen and P. E. Nielsen, Postgrad. Med. J.,56, Suppl. No. 2, 33–36 (1980).
T. J. Rimele, L. L. Aarhus, R. R. Lorenz, et al., J. Pharmacol. Exp. Ther.,231, 317–325 (1984).
M. Romo, P. Halttunen, P. Saarinen, et al., Ann. Clin. Res.,11, 249–252 (1979).
M. Sakanashi, S. Takeo, H. Ito, et al., Pharmacology,29, 241–246 (1984).
K. H. Sanders and N. Kolassa, N. S. Arch. Pharmacol.,329, Suppl., 79 (1985).
A. Semplicini, A. C. Ressina, G. P. Rossi, et al., Clin. Pharmacol. Ther.,33, 278–282 (1983).
C. Skinner, J. Gaddie, and K. N. V. Palmer, Br. Med. J.,2, 59–61 (1975).
M. Spedding, Br. J. Pharmacol.,4, 847P-848P (1981).
C. S. Sweet, J. Solar, and S. L. Gaul, Clin. Exp. Hypertens.,1, 449–471 (1979).
E. J. Sybertz, C. S. Sabin, K. K. Pula, et al., J. Pharmacol. Exp. Ther.,218, 435–443 (1981).
N. Takekoshi, E. Murakami, S. Matsui, et al., Jpn. Heart J.,24, 925–933 (1983).
H. Takemura, H. Ohshika, and M. Tanaka, Sapporo Med. J.,53, 353–358 (1984).
T. Takenaka, K. Shiono, K. Honda, et al., Clin. Exp. Hypertens.,A4, 125–137 (1982).
E. M. Taylor, D. Cameron, R. J. Eden, et al., J. Cardiovasc. Pharmacol.,3, 337–354 (1981).
E. M. Taylor, R. J. Eden, R. Fielden, et al., J. Cardiovasc. Pharmacol.,3, 355–368 (1981).
S. H. Taylor, Drugs,28, Suppl. No. 2, 69–87 (1981).
Ph. Tcherdakoff, Pharmatherapeutica,3, 342–348 (1983).
M. Thibonnier, M. D. Lardoux, and P. Corvol, Br. J. Clin. Pharmacol.,9, 561–567 (1980).
K. Tomioka, T. Yamada, and T. Takenaka, Arch. Int. Pharmacodyn.,256, 97–107 (1982).
Y. Uchida, M. Nakamura, S. Shimizu, et al., Arch. Int. Pharmacodyn.,262, 132–139 (1983).
E. M. Vaughan Williams, J. S. Millar, and T. J. Campbell, Cardiovasc. Res.,16, 233–239 (1982).
A. J. M. Verberne and M. J. Rand, Eur. J. Pharmacol.,108, 193–196 (1985).
H. J. Waal-Manning and F. O. Simpson, Br. J. Clin. Pharmacol.,13, No. 1, Suppl. 65S-73S (1982).
J. J. Walker, I. A. Greer, M. McLaren, et al., Br. J. Obstet. Gynaec.,90, 1094–1098 (1983).
J. K. Woodward and H. C. Cheng, J. Pharm. Pharmacol.,34, 193–195 (1982).
H. Zschedrich, W. Neuroh, J. Lutt, et al., Klin. Wochenschr.,61, 661–667 (1983).
Author information
Authors and Affiliations
Additional information
Translated from Khimiko-farmatsevticheskii Zhurnal, Vol. 20, No. 8, pp. 918–928, August, 1986.
Rights and permissions
About this article
Cite this article
Yuzhakov, C.D., Mashkovskii, M.D. β-Adrenergic blocking agents with α-adrenergic blocking and vasodilator activity (survey). Pharm Chem J 20, 532–540 (1986). https://doi.org/10.1007/BF00757631
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00757631